Market Tracker

02/05 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

36.67
Delayed Data
As of Feb 05
 -0.61 / -1.64%
Today’s Change
25.50
Today|||52-Week Range
43.63
-14.28%
Year-to-Date

Today’s Trading

Previous close37.28
Today’s open37.22
Day’s range36.42 - 37.64
Volume491,778
Average volume (3 months)737,933
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-61.22%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+19.34%
P/E ratio728.4
Price/Sales4.33
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...-2.25-1.84%
CXRXConcordia Healthcare...-0.54-1.80%
GLPGGalapagos NV-4.53-9.43%
TSROTESARO Inc-0.91-2.50%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts